Cargando…
Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
Autores principales: | Supady, Alexander, Duerschmied, Daniel, Bode, Christoph, Rieder, Marina, Lother, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439244/ https://www.ncbi.nlm.nih.gov/pubmed/32819415 http://dx.doi.org/10.1186/s13054-020-03238-1 |
Ejemplares similares
-
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation
por: Rieder, Marina, et al.
Publicado: (2020) -
Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019) -
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial
por: Rieder, Marina, et al.
Publicado: (2021) -
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial
por: Supady, Alexander, et al.
Publicado: (2021) -
Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study
por: Lang, Corinna N., et al.
Publicado: (2020)